It's easier now to treat opioid addiction with medication--but use has changed little
Abrupt policy shift removed a unique barrier to prescribing buprenorphine, but didn’t lead to a sharp rise in prescribing by the end of the first year
We're still accepting applications for fall 2024!
Apply TodayAbrupt policy shift removed a unique barrier to prescribing buprenorphine, but didn’t lead to a sharp rise in prescribing by the end of the first year
Worries that surgery patients would have a tougher recovery if their doctors had to abide by a five-day limit on opioid pain medication prescriptions didn’t play out as expected, a new study finds.
The University of Michigan recently received a $3.3 million grant to launch a comprehensive data science project that aims to inform best practices on pre- and post-surgical care procedures for patients with opioid use disorder.
A U-M research team finds that medications for opioid use disorder are rarely prescribed within 30 days of emergency department visits for opioid overdoses among patients with Medicaid
Relative to white patients, racial and ethnic groups saw a sharper decline in access to medicines to treat opioid use disorder during the early stages of the COVID-19 pandemic—intensifying pre-pandemic disparities, says a University of Michigan researcher.
Policy shift could improve access to buprenorphine for opioid use disorder, but stigma and training still pose significant challenge.